Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2017
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal ProtectionMarion M Mafham, Natalie Staplin, Jonathan Emberson, et al.Kidney International|October 2, 2004
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trialBengt Fellström, Hallvard Holdaas, Alan G Jardine, et al.Lancet (London, England)|June 20, 2003
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialHallvard Holdaas, Bengt Fellström, Alan G Jardine, et al.Journal of the American Society of Nephrology : JASN|May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney diseaseRichard Haynes, David Lewis, Jonathan Emberson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2026
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria A consensus report of the USA NKF Albuminuria - Proteinuria WorkshopStefan Ridderbos, Dominique van Mil, Bengt Fellström, et al.Kidney Medicine|January 3, 2023
Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical TrialObbo W Bredewold, Joe Chan, My Svensson, et al.Lab Animal|October 22, 2024
A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in miceLucas Rannier R A Carvalho, Miho Shimari, Ariela Maína Boeder, et al.Nature Medicine|May 25, 2024
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trialGlenn M Chertow, Anna Marie Chang, G Michael Felker, et al.Annals of Internal Medicine|November 3, 2025
Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysisHiddo J L Heerspink, Morgan E Grams, Yingying Sang, et al.European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.Pageof 9